SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-14-000358
Filing Date
2014-06-16
Accepted
2014-06-16 17:00:53
Documents
11
Period of Report
2014-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq1april3014f.htm 10-Q 235244
2 EXHIBIT 31.1 ex311.htm EX-31.1 7772
3 EXHIBIT 31.2 ex312.htm EX-31.2 7928
4 EXHIBIT 32.1 ex321.htm EX-32.1 5778
5 EXHIBIT 32.2 ex322.htm EX-32.2 5767
  Complete submission text file 0001511164-14-000358.txt   2546847

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neukf-20140430.xml EX-101.INS 337824
7 XBRL TAXONOMY EXTENSION SCHEMA neukf-20140430.xsd EX-101.SCH 39518
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20140430_cal.xml EX-101.CAL 2941
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20140430_def.xml EX-101.DEF 57716
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20140430_lab.xml EX-101.LAB 145790
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20140430_pre.xml EX-101.PRE 137042
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 14923382
SIC: 2834 Pharmaceutical Preparations